ZAMPINI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 2.574
EU - Europa 1.170
AS - Asia 284
SA - Sud America 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.042
Nazione #
US - Stati Uniti d'America 2.547
UA - Ucraina 291
SE - Svezia 172
IE - Irlanda 150
IT - Italia 150
DE - Germania 148
DK - Danimarca 108
TR - Turchia 91
CN - Cina 65
FI - Finlandia 65
KR - Corea 59
SG - Singapore 54
GB - Regno Unito 38
CA - Canada 26
BE - Belgio 20
FR - Francia 20
IN - India 6
EC - Ecuador 5
AU - Australia 4
JP - Giappone 4
EU - Europa 3
CH - Svizzera 2
PK - Pakistan 2
AT - Austria 1
BR - Brasile 1
CL - Cile 1
EE - Estonia 1
HK - Hong Kong 1
MD - Moldavia 1
NL - Olanda 1
PA - Panama 1
PH - Filippine 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 4.042
Città #
Chandler 335
Jacksonville 299
Fairfield 230
Ashburn 190
Des Moines 154
Wilmington 152
Dublin 149
Woodbridge 115
Seattle 108
Houston 94
Ann Arbor 91
Boardman 86
New York 78
Cambridge 73
Lawrence 61
Princeton 61
San Mateo 60
Turin 30
Beijing 29
Ottawa 25
Centro 24
San Diego 22
Brussels 19
Los Angeles 15
Washington 15
Hanover 7
Helsinki 7
Norwalk 7
Rome 7
Guangzhou 6
Redmond 6
London 5
Pune 5
Quito 5
Treviso 5
Marche 4
Porto 4
Buffalo 3
Civitanova Marche 3
Rostock 3
Shanghai 3
Sydney 3
Aosta 2
Ascoli Piceno 2
Falconara Marittima 2
Izmir 2
Jiaxing 2
Kilburn 2
Messina 2
Nyon 2
Pesaro 2
Portovenere 2
Redwood City 2
Seoul 2
Serra 2
Shenzhen 2
Skanderborg 2
Tokyo 2
Acton 1
Amsterdam 1
Ancona 1
Angeles City 1
Ankara 1
Atlanta 1
Berlin 1
Bologna 1
Bratislava 1
Chicago 1
Chiswick 1
Dallas 1
Domusnovas 1
Dong Ket 1
Edinburgh 1
Florence 1
Frankfurt am Main 1
Groves 1
Istanbul 1
Kinnegad 1
Kunshan 1
Liège 1
Milan 1
Modena 1
Monsampolo Del Tronto 1
Mountain View 1
New Bedfont 1
Newmarket 1
Nürnberg 1
Panama City 1
Paris 1
Perth 1
Phoenix 1
Picerno 1
Pistoia 1
Ruvo Di Puglia 1
Seebruck 1
Shaoxing 1
Simi Valley 1
Singapore 1
Strasbourg 1
Tallinn 1
Totale 2.672
Nome #
Early biochemical effects of velmanase alfa in a 7-month-old infant with alpha-mannosidosis 158
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone 107
Caratterizzazione dei glicosaminoglicani del latte umano e del latte vaccino: risultati preliminari 95
Effect of Holder Pasteurisation on Human Milk Glycosaminoglycans 92
Human milk glycosaminoglycans inhibit in vitro the adhesion of Escherichia coli and Salmonella fyris to human intestinal cells 89
Age-related modulation of plasmatic beta-Galactosidase activity in healthy subjects and in patients affected by T2DM 88
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient. 86
Early diagnosis of mucopolysaccharidoses in developing countries: A low cost and easy execution approach 85
ruolo dei prebiotici nel processo di ottimizzazione delle formule del commercio 83
I prebiotici 81
Oligosaccharides in 4 Different Milk Groups, Bifidobacteria, and Ruminococcus obeum. 80
Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype 80
Breast milk oligosaccharides: effects of 2′-fucosyllactose and 6′-sialyllactose on the adhesion of Escherichia coli and Salmonella fyris to Caco-2 cells 79
3-fucosyl-lactose inhibits the adhesion of Escherichia coli to Caco-2 cells 77
Human milk glycosaminoglycans 77
Preterm milk oligosaccharides during the first month of lactation 76
Prebiotics in infant formulas: biochemical characterization by thyn layer chromatography and high performance anion exchange chromatography 76
I Prebiotici 75
Importance of the combined urinary procedure for the diagnosis of Mucopolysaccharidoses 74
Effect of 6 years enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 74
Oligosaccharides of human milk inhibit the adhesion of Listera monocytogenes to Caco-2 cells 72
Gli idrati del carbonio del latte umano 71
Composition and structure elucidation of human milk glycosaminoglycans. 71
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 68
Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli,Vibrio cholerae and Salmonella fyris 67
Syalil-oligosaccharides inhibit the adhesion of E. coli and S. fyrys to Caco-2 cells 66
Gliadin-peptide induces Caco-2 monolayer permeability and tight junctions protein ZO-1 redistribution 66
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3days of age for early diagnosis application 66
I carboidrati del latte umano e delle formule del commercio 65
Prebiotics of human milk and infant formulas 65
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine 65
Oligosaccharidesof human milk as polyfunctional nutrients 64
High-throughput determination of urinary hexosamines for diagnosis of mucopolysaccharidoses by capillary electrophoresis and high-performance liquid chromatography. 64
Composizione e ruolo fisiologico dei carboidrati del latte umano pretermine 64
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 64
Gliadin, zonulin and gut permeability: effect on celiac and non-celiac mucosa and intestinal cell lines 62
On-line high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry profiling of human milk oligosaccharides dervatized with 2-aminoacridone 62
Multiple sulfatase deficiency with neonatal manifestation. 62
Le malattie rare: dall'ambulatorio del pediatra alla terapia enzimatica. Le Mucopolisaccaridosi 61
Effects of holder pasteurization on human milk oligosaccharides. 60
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns 59
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients. 59
Bone marrow transplantation in Hunter syndrome 58
False positive screen test for mucopolysaccharidoses in healthy female newborns 58
Human Milk Glycosaminoglycans as Possible Bioactive Substances for the Breastfed Newborn. 57
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 57
Characterization of carbohydrates in commercial infant formulae 55
Structural characterization of chondroitin sulfate from Italian cheese Parmigiano Reggiano 54
Plasmatic and urinary glycosaminoglycans characterization in Mucopolysaccharidosis II patient treated with enzyme-replacement therapy with idursulfate 54
Glycosaminoglycan content in term and preterm milk during the first month of lactation 54
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses. 53
Short and reliable method for mucopolysaccharidoses diagnosis 52
Modello in vitro per lo studio degli effetti della gliadina sulla permeabilità intestinale 52
Metabolic fate of human milk oligosaccharides in four different group of milk in breastfed infants 50
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of mucopolysaccharidosis type IIIA. 50
Human milk glycosaminoglycans in feces of breastfed newborns: preliminary structural elucidation and possible biological role. 47
Human milk glycosaminoglycans: the state of the art and future perspectives 46
I prebiotici 42
Function of human milk oligosaccharides in the protection of newborns against infections 40
Sialyl-oligosaccharides inhibit the adhesion of E. coli and S. fyrys to Caco-2 cells 39
Metabolic fate of oligosaccharides from human milk 36
First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha-mannosidosis 5
Totale 4.114
Categoria #
all - tutte 19.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 0 7
2019/2020397 9 5 65 0 62 14 65 3 70 11 15 78
2020/20211.018 70 93 171 11 93 54 183 44 96 59 104 40
2021/2022497 25 129 13 18 9 24 26 24 35 60 40 94
2022/20231.069 80 131 82 78 63 239 0 67 234 3 67 25
2023/2024554 97 15 31 75 75 138 4 39 6 23 2 49
Totale 4.114